Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001 - PubMed (original) (raw)
. 2004 Nov 15;190(10):1739-44.
doi: 10.1086/425018. Epub 2004 Oct 7.
Affiliations
- PMID: 15499527
- DOI: 10.1086/425018
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001
James R Johnson et al. J Infect Dis. 2004.
Abstract
Background: Increases in antimicrobial resistance in Escherichia coli have been paralleled by an increasing incidence of E. coli sepsis, suggesting a possible link between resistance and virulence.
Methods: All 76 multidrug-resistant (MDR) E. coli isolates (i.e., those resistant to > or =3 antimicrobial agents, including ampicillin, ceftazidime, trimethoprim-sulfamethoxazole, gentamicin, and ciprofloxacin) reported to the Tracking Resistance in the United States Today studies during 2000-2001 and 76 closely matched pansusceptible control isolates were studied. Extended virulence profiles and E. coli phylogenetic group (A, B1, B2, or D) were compared between groups.
Results: The MDR isolates, which represented predominantly non-B2 phylogenetic groups (91%), exhibited significantly reduced molecular virulence, compared with the predominantly group B2-derived control isolates (58%). Only 30% of MDR isolates, compared with 61% of control isolates (P<.001), qualified as extraintestinal pathogenic E. coli (ExPEC), and even these isolates exhibited significantly lower virulence scores than did susceptible ExPEC (7.25 vs. 9.0; P=.001). Phylogenetic differences accounted for the apparent virulence differences between MDR and control isolates.
Conclusions: These findings argue against a direct link between virulence traits and antimicrobial resistance in E. coli. Instead, they call into question why non-B2 strains are more commonly MDR, with differential exposure to selection pressure (including in agriculture) as one possible explanation.
Similar articles
- National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, García-Garrote F, Chaves F, Orellana MÁ, Martínez-Martínez L, Calvo J, Prats G, Larrosa MN, González-López JJ, López-Cerero L, Rodríguez-Baño J, Pascual A. Blanco J, et al. J Antimicrob Chemother. 2011 Sep;66(9):2011-21. doi: 10.1093/jac/dkr235. Epub 2011 Jun 13. J Antimicrob Chemother. 2011. PMID: 21669946 - Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A. Moreno E, et al. J Antimicrob Chemother. 2006 Feb;57(2):204-11. doi: 10.1093/jac/dki468. Epub 2006 Jan 3. J Antimicrob Chemother. 2006. PMID: 16390858 - Virulence factors of septicemic Escherichia coli strains.
Mokady D, Gophna U, Ron EZ. Mokady D, et al. Int J Med Microbiol. 2005 Oct;295(6-7):455-62. doi: 10.1016/j.ijmm.2005.07.007. Int J Med Microbiol. 2005. PMID: 16238019 Review.
Cited by
- Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.
Capett MS, Vollú-Silva P, Melchiades VA, Bokehi LC, Araújo FM, Martins IS, Neves FPG, Gonzalez AGM, Oswald E, de Paula GR, Teixeira LA. Capett MS, et al. Curr Microbiol. 2016 Nov;73(5):624-632. doi: 10.1007/s00284-016-1104-y. Epub 2016 Jul 26. Curr Microbiol. 2016. PMID: 27460583 - Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.
Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. Kudinha T, et al. J Clin Microbiol. 2013 Oct;51(10):3270-6. doi: 10.1128/JCM.01315-13. Epub 2013 Jul 24. J Clin Microbiol. 2013. PMID: 23885001 Free PMC article. - Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children.
Qin X, Razia Y, Johnson JR, Stapp JR, Boster DR, Tsosie T, Smith DL, Braden CR, Gay K, Angulo FJ, Tarr PI. Qin X, et al. Antimicrob Agents Chemother. 2006 Oct;50(10):3325-9. doi: 10.1128/AAC.00548-06. Antimicrob Agents Chemother. 2006. PMID: 17005812 Free PMC article. - Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands.
Koningstein M, van der Bij AK, de Kraker ME, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, Leverstein-van Hall MA; ISIS-AR Study Group. Koningstein M, et al. PLoS One. 2014 Jan 28;9(1):e86634. doi: 10.1371/journal.pone.0086634. eCollection 2014. PLoS One. 2014. PMID: 24489755 Free PMC article. - Genomic Insights into Drug Resistance and Virulence Platforms, CRISPR-Cas Systems and Phylogeny of Commensal E. coli from Wildlife.
Alonso CA, de Toro M, de la Cruz F, Torres C. Alonso CA, et al. Microorganisms. 2021 May 5;9(5):999. doi: 10.3390/microorganisms9050999. Microorganisms. 2021. PMID: 34063152 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous